Investigations conducted on mice with HFD induced obesity suggest that increased expression of SREBP-2 is intricately associated with cholesterol deposition in renal cells as well as impaired kidney functions (68–70). Here, SREBF2 is linked to obesity due to melanocortin 4 receptor deficiency.